CYCLO THERAPEUTICS INC (CYTH)

US23254X2018 - Common Stock

1.39  -0.01 (-0.71%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
955.48K1.38M1.59M900.00K1.01M
Cost Of Goods
99.61K150.00K170.00K70.00K80.00K
Gross Profit
855.87K1.23M1.42M830.00K920.00K
Operating Expenses
20.24M16.85M15.71M9.79M8.32M
Research and Development
13.22M9.00M9.15M6.10M4.87M
Selling, General, and Administrative Expenses
7.01M7.83M6.54M3.68M3.44M
Operating Income
-19.39M-15.62M-14.29M-8.96M-7.39M
Interest Income/Expense
-3.89K10.00K0.0020.00K10.00K
Non Recurring Items
N/A160.00KN/A0.00-150.00K
Income Before Taxes
-19.40M-15.45M-14.29M-8.94M-7.53M
Income Tax
N/A0.000.00N/A0.00
Net Income
-19.40M-15.45M-14.29M-8.94M-7.53M
EBITDA
N/A-15.60M-14.27M-8.95M-7.38M
 
Per Share Data
EPS Diluted Total Ops
-1.67-1.83-2.24-5.59-6.96
Non GAAP EPS
N/A-1.83-2.30N/AN/A
 
Statistics
Gross Profit Margin
89.57%89.13%89.31%92.22%91.09%
Profit Margin
-2030.53%-1119.57%-898.74%-993.33%-745.54%
Operating Profit Margin
-2029.08%-1131.88%-898.74%-995.56%-731.68%

All data in USD

Charts